08:58 AM EDT, 06/18/2024 (MT Newswires) -- Grifols ( GRFS ) said Tuesday it has sold a 20% stake in blood products company Shanghai RAAS to Haier Group for 12.50 billion Chinese renminbi ($1.72 billion) through a repurchase deal, retaining a 6.58% stake and a board seat.

The plasma-derived medicines manufacturer said the two companies have also extended their albumin distribution deal for 10 years, with an option to extend through 2044.

Price: 7.23, Change: +0.13, Percent Change: +1.83